论文部分内容阅读
基质金属蛋白酶9(Matrix Metalloproteinase-9,MMP-9)及其抑制剂(TIMP-1)在脓毒症急性肺损伤的发生发展中起着重要作用,成为临床治疗一个新的靶点。
Matrix Metalloproteinase-9 (MMP-9) and its inhibitor (TIMP-1) play an important role in the pathogenesis of sepsis-induced acute lung injury and become a new target for clinical treatment.